UBS Group’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-200
Closed -$3.52K 9499
2024
Q1
$3.52K Sell
200
-16,200
-99% -$239K ﹤0.01% 7736
2023
Q4
$259K Buy
+16,400
New +$169K ﹤0.01% 5607

Other funds holding ASPN

UBS Group's ASPN Position: Q2 2026 in Review

UBS Group reduced its Aspen Aerogels (ASPN) stake by 65% in Q2 2026, selling an estimated $601K and leaving 66,671 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #6348.

UBS Group first reported a position in ASPN in Q4 2014 and has held it in 40 quarters since. The position peaked at $5.28M in Q1 2024. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • UBS Group held 66,671 shares of Aspen Aerogels worth $423K as of Q2 2026.
  • UBS Group sold 122,558 Aspen Aerogels shares in Q2 2026, an estimated $601K.
  • Aspen Aerogels made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6348 holding.
  • UBS Group first reported a position in Aspen Aerogels in Q4 2014 and has held it in 40 quarters since.
  • UBS Group's Aspen Aerogels position peaked at $5.28M in Q1 2024.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.